Latest Posts › Japan

Share:

The impact of COVID-19 on clinical trials and countermeasure development in Japan

On 19 March 2020, the Ministry of Health, Labour and Welfare of Japan (MHLW) issued a notice announcing a waiver of the statutorily-required waiting period after submitting a request for clinical trial to the MHLW in respect...more

Update of Japan’s Privacy Law Approved by Cabinet

On Tuesday, March 10, the Japanese Cabinet approved a bill to revise the Act on the Protection of Personal Information (“APPI”), which would require companies to take certain additional measures to protect personal data of...more

Japan waives clinical trial waiting period for COVID-19 treatments

On 19 March 2020, the Ministry of Health, Labour and Welfare of Japan (MHLW) issued a notice announcing a waiver of the statutorily-required waiting period after submitting a request for clinical trial to the MHLW in respect...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide